Набор от данни:  Актуализация на регистрите на НСЦРЛП към 02.01.2020

одобрен

Приложение 4 на ПЛС от 02.01.2020 г.

Уникален идентификатор:  40a0e959-8b4e-4eb6-a17f-27ef6314b392

Текуща версия: 1

Показвана версия: 1

Формат: CSV

  • Създаден на: 2020-01-02 14:22:43
  • Създаден от: georgi_sivchev
  • Последна промяна: 2020-01-02 14:22:43
записа на страница
Подреди по:
Възходящ ред Низходящ ред

ПОЗИТИВЕН ЛЕКАРСТВЕН СПИСЪК

Coagulation factor VIII (Octocog alfa) EU/1/03/271/002 Advate 500 IU, Powder and solvent for solution for injection, 500, IU, Pack: 1 vial powder + 1 vial solvent (5 ml) + reconstitution device Baxter AG, Австрия Baxter SA., Belgium; Baxalta Belgium Manufacturing SA, Белгия 560.48 112.1 672.58 4% 10 570.48 114.1 684.58 16% 25 595.48 119.1 714.58 Протокол №224/18.05.2017; промяна на обстоятелства НСР-15263/15.03.2018 НСР-2214/20.12.2013; НСР-15430/19.04.2018 04.05.2018 02.06.2018 Активен 2443
Coagulation factor VIII (Octocog alfa) EU/1/03/271/002 Advate 500 IU, Powder and solvent for solution for injection, 500, IU, Pack: 1 vial powder + 1 vial solvent (5 ml) + reconstitution device Baxter AG, Австрия Baxter SA., Belgium; Baxalta Belgium Manufacturing SA, Белгия 560.48 112.1 672.58 4% 10 570.48 114.1 684.58 16% 25 595.48 119.1 714.58 Протокол №224/18.05.2017; промяна на обстоятелства НСР-15263/15.03.2018 НСР-2214/20.12.2013; НСР-15430/19.04.2018 04.05.2018 02.06.2018 Неактивен 2443
Coagulation factor VIII (Octocog alfa) EU/1/03/271/002 Advate 500 IU, Powder and solvent for solution for injection, 500, IU, Pack: 1 vial powder + 1 vial solvent (5 ml) + reconstitution device Baxter AG, Австрия Baxter SA., Belgium; Baxalta Belgium Manufacturing SA, Белгия 568.19 113.64 681.83 4% 10 578.19 115.64 693.83 16% 25 603.19 120.64 723.83 Протокол №224/18.05.2017; промяна на обстоятелства НСР-15263/15.03.2018 НСР-2214/20.12.2013 06.02.2014 02.04.2018 Неактивен 2443
Coagulation factor VIII (Octocog alfa) EU/1/03/271/002 Advate 500 IU, Powder and solvent for solution for injection, 500, IU, Pack: 1 vial powder + 1 vial solvent (5 ml) + reconstitution device Baxter AG, Австрия Baxter SA., Belgium 568.19 113.64 681.83 4% 10 578.19 115.64 693.83 16% 25 603.19 120.64 723.83 Протокол №224/18.05.2017 НСР-2214/20.12.2013 06.02.2014 02.06.2017 Неактивен 2443
Coagulation factor VIII (Octocog alfa) EU/1/03/271/002 Advate 500 IU, Powder and solvent for solution for injection, 500, IU, Pack: 1 Baxter AG, Австрия Baxter SA., Belgium 568.19 113.64 681.83 4% 10 578.19 115.64 693.83 16% 25 603.19 120.64 723.83 НСР-2214/20.12.2013 06.02.2014 06.02.2014 Неактивен 2443
Coagulation factor VIII (Octocog alfa) EU/1/03/271/002 Advate 500 IU, Powder and solvent for solution for injection, 500, IU, Pack: 1 Baxter AG, Австрия Baxter SA., Belgium 568.19 113.64 681.83 4% 10 578.19 115.64 693.83 16% 25 603.19 120.64 723.83 НСР-2214/20.12.2013 06.02.2014 06.02.2014 Неактивен 2443
Coagulation factor VIII (Octocog alfa) EU/1/03/271/002 Advate 500 IU, Powder and solvent for solution for injection, 500, IU, Pack: 1 Baxter AG, Австрия Baxter SA., Belgium 733.44 146.69 880.13 4% 10 743.44 148.69 892.13 16% 25 768.44 153.69 922.13 КЦРР-259/06.03.2012 21.03.2012 21.03.2012 Неактивен 2443
Coagulation factor VIII (Octocog alfa) EU/1/03/271/002 Advate 500 IU, Powder and solvent for solution for injection, 500, IU, Pack: 1 Baxter AG, Австрия Baxter SA., Belgium 758.67 151.73 910.4 6% 15 773.67 154.73 928.4 18% 30 803.67 160.73 964.4 КЦ-950/10.06.2009 30.06.2009 30.06.2009 Неактивен 2443
Coagulation factor VIII (rurioctocog alfa pegol) EU/1/17/1247/010 Adynovi, Powder and solvent for injection, 1000, IU, Pack: 1 vial + 1 vial (solvent 2 ml), preassembled whit reconstitution device Baxalta Innovations GmbH, Австрия Baxalta Belgium Manufacturing, Belgium 1609.3 321.86 1931.16 4% 10 1619.3 323.86 1943.16 16% 25 1644.3 328.86 1973.16 НСР-17647/21.12.2018 предварително изпълнение 21.12.2018 02.01.2019 Активен 16388
Coagulation factor VIII (rurioctocog alfa pegol) EU/1/17/1247/010 Adynovi, Powder and solvent for injection, 1000, IU, Pack: 1 vial + 1 vial (solvent 2 ml), preassembled whit reconstitution device Baxalta Innovations GmbH, Австрия Baxalta Belgium Manufacturing, Belgium 1609.3 321.86 1931.16 4% 10 1619.3 323.86 1943.16 16% 25 1644.3 328.86 1973.16 НСР-17647/21.12.2018 предварително изпълнение 21.12.2018 02.01.2019 Неактивен 16388
Coagulation factor VIII (rurioctocog alfa pegol) EU/1/17/1247/006 Adynovi, Powder and solvent for injection, 500, IU, Pack: 1 vial + 1 vial (solvent 2 ml), preassembled whit reconstitution device Baxalta Innovations GmbH, Австрия Baxalta Belgium Manufacturing, Belgium 804.65 160.93 965.58 4% 10 814.65 162.93 977.58 16% 25 839.65 167.93 1007.58 НСР-17647/21.12.2018 предварително изпълнение 21.12.2018 02.01.2019 Активен 16387
Coagulation factor VIII (rurioctocog alfa pegol) EU/1/17/1247/006 Adynovi, Powder and solvent for injection, 500, IU, Pack: 1 vial + 1 vial (solvent 2 ml), preassembled whit reconstitution device Baxalta Innovations GmbH, Австрия Baxalta Belgium Manufacturing, Belgium 804.65 160.93 965.58 4% 10 814.65 162.93 977.58 16% 25 839.65 167.93 1007.58 НСР-17647/21.12.2018 предварително изпълнение 21.12.2018 02.01.2019 Неактивен 16387
Olanzapine 20100375 AEDON, Orodispersible tablet, 10, mg, Pack: 30 G. L. Pharma GmbH, Австрия Pharmathen S.A.Гърция 18.05 3.61 21.66 6% 1.08 19.13 3.83 22.96 18% 3.25 22.38 4.48 26.86 НСР-3987/30.06.2014; НСР-9586/23.06.2016 15.07.2014 02.08.2016 Заличен 3019
Olanzapine 20100375 AEDON, Orodispersible tablet, 10, mg, Pack: 30 G. L. Pharma GmbH, Австрия Pharmathen S.A.Гърция 18.05 3.61 21.66 6% 1.08 19.13 3.83 22.96 18% 3.25 22.38 4.48 26.86 НСР-3987/30.06.2014 15.07.2014 15.07.2014 Неактивен 3019
Olanzapine 20100373 AEDON, Orodispersible tablet, 5, mg, Pack: 30 G. L. Pharma GmbH, Австрия Pharmathen S.A.Гърция 5.52 1.1 6.62 7% 0.39 5.91 1.18 7.09 20% 1.1 7.01 1.4 8.41 НСР-3986/30.06.2014; НСР-9586/23.06.2016 15.07.2014 02.08.2016 Заличен 3020
Olanzapine 20100373 AEDON, Orodispersible tablet, 5, mg, Pack: 30 G. L. Pharma GmbH, Австрия Pharmathen S.A.Гърция 5.52 1.1 6.62 7% 0.39 5.91 1.18 7.09 20% 1.1 7.01 1.4 8.41 НСР-3986/30.06.2014 15.07.2014 15.07.2014 Неактивен 3020
Olanzapine № - 12525/21.03.2011 AEDON, Orodispersible tablet, 10, mg, Pack: 30 G. L. Pharma GmbH, Австрия Pharmathen S.A.Гърция 18.68 3.74 22.42 6% 1.12 19.8 3.96 23.76 18% 3.36 23.16 4.63 27.79 НСР-1524/25.10.2013 11.11.2013 11.11.2013 Неактивен 3019
Olanzapine № - 12524/21.03.2011 AEDON, Orodispersible tablet, 5, mg, Pack: 30 G. L. Pharma GmbH, Австрия Pharmathen S.A.Гърция 5.71 1.14 6.85 7% 0.4 6.11 1.22 7.33 20% 1.14 7.25 1.45 8.7 НСР-1511/25.10.2013 11.11.2013 11.11.2013 Неактивен 3020
Olanzapine № - 12525/21.03.2011 AEDON, Orodispersible tablet, 10, mg, Pack: 30 G. L. Pharma GmbH, Австрия Pharmathen S.A.Гърция 74.32 14.86 89.18 4% 2.97 77.29 15.46 92.75 16% 11.89 89.18 17.84 107.02 КЦ-2424/06.07.2011 20.07.2011 20.07.2011 Неактивен 3019
Olanzapine № - 12524/21.03.2011 AEDON, Orodispersible tablet, 5, mg, Pack: 30 G. L. Pharma GmbH, Австрия Pharmathen S.A.Гърция 37.16 7.43 44.59 4% 1.49 38.65 7.73 46.38 16% 5.95 44.6 8.92 53.52 КЦ-2424/06.07.2011 20.07.2011 20.07.2011 Неактивен 3020
Salmeterol, Fluticasone EU/1/16/1122/001 Aerivio Spiromax, Inhalation powder, 50 mcg/500 mcg, -, Pack: 1 inhaler (60 doses) Teva B.V., Нидерландия Norton (Waterford) Limited T/A Teva Pharmaceuticals Ireland, Ирландия; Teva Pharmaceuticals Europe B.V., Нидерландия 51.71 10.34 62.05 4% 2.07 53.78 10.76 64.54 16% 8.27 62.05 12.41 74.46 НСР-12270/07.04.2017; НСР-15920/15.06.2018; НСР-18913/06.06.2019 30.06.2018 02.07.2019 Заличен 15649
Salmeterol, Fluticasone EU/1/16/1122/001 Aerivio Spiromax, Inhalation powder, 50 mcg/500 mcg, -, Pack: 1 inhaler (60 doses) Teva B.V., Нидерландия Norton (Waterford) Limited T/A Teva Pharmaceuticals Ireland, Ирландия; Teva Pharmaceuticals Europe B.V., Нидерландия 51.71 10.34 62.05 4% 2.07 53.78 10.76 64.54 16% 8.27 62.05 12.41 74.46 НСР-12270/07.04.2017; НСР-15920/15.06.2018 30.06.2018 02.07.2018 Неактивен 15649
Salmeterol, Fluticasone EU/1/16/1122/001 Aerivio Spiromax, Inhalation powder, 50 mcg/500 mcg, -, Pack: 1 inhaler (60 doses) Teva B.V., Нидерландия Norton (Waterford) Limited T/A Teva Pharmaceuticals Ireland, Ирландия; Teva Pharmaceuticals Europe B.V., Нидерландия 60.63 12.13 72.76 4% 2.43 63.06 12.61 75.67 16% 9.7 72.76 14.55 87.31 НСР-12270/07.04.2017 22.04.2017 02.05.2017 Неактивен 15649
Isoflurane 20020030 Aerrane, Inhalation vapour, liquid, 250, ml, Pack: 1 Бакстер България ЕООД, България Baxter SA, Boulevard Rene Branquart 80, 7860 Lessines, Белгия; Baxter Manufacturing Sp z.o.o., Полша 114.34 22.87 137.21 4% 4.57 118.91 23.78 142.69 16% 18.29 137.2 27.44 164.64 промяна на обстоятелства НСР-4890/22.10.2014; НСР-7100/15.09.2015; промяна на обстоятелства НСР-12882/02.06.2017 НСР-822/07.08.2013 29.08.2013 02.07.2017 Активен 2037
Isoflurane II-0410/ 08.08.2007 Aerrane, Inhalation vapour, liquid, 250, ml, Pack: 1 Бакстер България ЕООД, България Baxter SA, Boulevard Rene Branquart 80, 7860 Lessines, Белгия; Baxter Manufacturing Sp z.o.o., Полша 114.34 22.87 137.21 4% 4.57 118.91 23.78 142.69 16% 18.29 137.2 27.44 164.64 промяна на обстоятелства НСР-4890/22.10.2014; НСР-7100/15.09.2015 НСР-822/07.08.2013 29.08.2013 29.08.2013 Неактивен 2037
Показва 275 до 299 от общо 16959 записа
Линк за сваляне в CSV формат: Копирай
Линк за сваляне в JSON формат: Копирай
Линк за сваляне в XML формат: Копирай
 

Моля изчакайте